Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ullrich

Showing results (41-50 of 196) with videos related to

Pageof 20
Sort By:
European Journal of Radiology|June 7, 2017
Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image qualityT Ullrich, M Quentin, C Oelers, et al.
Pharmacology, Biochemistry, and Behavior|July 12, 2005
The stimulus properties of LSD in C57BL/6 miceJ C Winter, A K Kieres, M D Zimmerman, et al.
Pathology Oncology Research : POR|July 14, 2021
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous <i>Kras</i> <sup>LSL-G12V</sup> Driven Lung Cancer Mouse ModelLydia Meder, Alexandra Florin, Luka Ozretić, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinibCarsten Kobe, Matthias Scheffler, Arne Holstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PETDeniz Kahraman, Matthias Scheffler, Thomas Zander, et al.
European Journal of Radiology|February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsyM Klingebiel, C Arsov, T Ullrich, et al.
Magnetic Resonance Imaging|June 15, 2018
Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomyF Ziayee, A Müller-Lutz, J Gross, et al.
Abdominal Radiology (New York)|January 16, 2021
Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancerB Valentin, L Schimmöller, T Ullrich, et al.
Abdominal Radiology (New York)|October 31, 2023
MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancerM Boschheidgen, L Schimmöller, R Kastl, et al.
European Journal of Radiology|October 22, 2023
Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancerR Al-Monajjed, J P Radtke, M Thomas, et al.
Pageof 20

Showing results (41-50 of 196) with videos related to

Sort By:
Pageof 20
European Journal of Radiology|June 7, 2017
Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image qualityT Ullrich, M Quentin, C Oelers, et al.
Pharmacology, Biochemistry, and Behavior|July 12, 2005
The stimulus properties of LSD in C57BL/6 miceJ C Winter, A K Kieres, M D Zimmerman, et al.
Pathology Oncology Research : POR|July 14, 2021
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous <i>Kras</i> <sup>LSL-G12V</sup> Driven Lung Cancer Mouse ModelLydia Meder, Alexandra Florin, Luka Ozretić, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinibCarsten Kobe, Matthias Scheffler, Arne Holstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PETDeniz Kahraman, Matthias Scheffler, Thomas Zander, et al.
European Journal of Radiology|February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsyM Klingebiel, C Arsov, T Ullrich, et al.
Magnetic Resonance Imaging|June 15, 2018
Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomyF Ziayee, A Müller-Lutz, J Gross, et al.
Abdominal Radiology (New York)|January 16, 2021
Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancerB Valentin, L Schimmöller, T Ullrich, et al.
Abdominal Radiology (New York)|October 31, 2023
MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancerM Boschheidgen, L Schimmöller, R Kastl, et al.
European Journal of Radiology|October 22, 2023
Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancerR Al-Monajjed, J P Radtke, M Thomas, et al.
Pageof 20